Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School

Last Updated: March 30, 2023

Investigational Drugs with Clinical Trials for: Carcinoma, Ovarian Epithelial

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $100
Remove trial restrictions

Drugname Indication
AZD9291 Carcinoma, Ovarian Epithelial
Zibotentan Carcinoma, Ovarian Epithelial
Lurtotecan Carcinoma, Ovarian Epithelial
Tocotrienol Carcinoma, Ovarian Epithelial
GDC-0077 Carcinoma, Ovarian Epithelial
Oxamic Acid Carcinoma, Ovarian Epithelial
Taselisib Carcinoma, Ovarian Epithelial
>Drugname >Indication

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.